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In March 2012, World Health Organization recommended that HIV testing should be offered
to all patients with presumptive TB (previously called TB suspects). How this is best imple-
mented and monitored in routine health care settings in India was not known. An operational
research was conducted in Karnataka State (South India, population 64 million, accounts
for 10% of India’s HIV burden), to test processes and learn results and challenges of
screening presumptive TB patients for HIV within routine health care settings.
Methods
In this cross-sectional study conducted between January-March 2012, all presumptive TB
patients attending public sector sputum microscopy centres state-wide were offered HIV
testing by the laboratory technician, and referred to the nearest public sector HIV counsel-
ling and testing services, usually within the same facility. The HIV status of the patients was
recorded in the routine TB laboratory form and TB laboratory register. The laboratory regis-
ter was compiled to obtain the number of presumptive TB patients whose HIV status was
ascertained, and the number found HIV positive. Aggregate data on reasons for non-testing
were compiled at district level.
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Results
Overall, 115,308 patients with presumptive TB were examined for sputum smear micros-
copy at 645 microscopy centres state-wide. Of these, HIV status was ascertained for
62,847(55%) among whom 7,559(12%) were HIV-positive, and of these, 3,034(40%)
were newly diagnosed. Reasons for non-testing were reported for 37,700(72%) of the
52,461 patients without HIV testing; non-availability of testing services at site of sputum
collection was cited by health staff in 54% of respondents. Only 4% of patients opted out
of HIV testing.
Conclusion
Offering HIV testing routinely to presumptive TB patients detected large numbers of previ-
ously-undetected instances of HIV infection. Several operational challenges were noted
which provide useful lessons for improving uptake of HIV testing in this important group.
Introduction
According to the World Health Organization (WHO) Global TB Report 2014, an estimated 1.1
million people globally had HIV-associated tuberculosis (TB), and 360,000 died from HIV-
associated TB in 2013. [1] Three important reasons have been given for this unacceptably high
death rate: i) in persons with HIV/AIDS, TB was not diagnosed and treated; ii) in patients with
TB, HIV was not diagnosed and thus co-infected patients were not referred to HIV care and
treatment; and iii) when the two diseases were diagnosed and treated, this often happened far
too late to be effective.[2]
In March 2012, WHO launched its updated policy on collaborative TB/HIV activities to
reduce the burden of TB and HIV. This policy uses the same framework as the 2004 WHO Pol-
icy of TB/HIV collaborative activities, but includes some important new recommendations,
one of which is that routine HIV testing and counselling should be offered not only to patients
diagnosed with TB, but also to those with presumptive TB (previously called TB suspects).[3]
This recommendation was based on the findings from studies done predominantly in sub-
Saharan African countries, which show a high HIV prevalence among patients with presump-
tive TB ranging from 27%-64%, sometimes even higher than HIV prevalence among TB
patients.[4–10] However, these findings from HIV endemic settings were not generalizable to
India, a country with a ‘concentrated’HIV epidemic (meaning HIV prevalence in general pop-
ulation remains lower than 1%).[11] Hence, despite recommendations fromWHO, routine
HIV testing had been offered only to ‘TB patients’ and not to all ‘patients with presumptive TB’
in India. Operational research conducted in two districts of South India in 2010 showed that
the HIV prevalence among presumptive TB patients can be as high as that among TB patients
ranging from 7%-10%, and that ‘Provider initiated HIV testing and counselling’ (PITC, a term
used when health care providers actively offer the HIV testing to certain patient groups)
among presumptive TB patients can be feasibly implemented in settings with decentralized
HIV testing facilities with potential for increased HIV case finding, early treatment initiation
and reduction in mortality and morbidity.[12, 13]
The National Technical Working Group (NTWG) for joint TBHIV collaborative activities
in India acknowledged the strong evidence and took a policy decision to implement PITC
among presumptive TB patients in high HIV settings in India.[14] However, how this is best
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implemented and monitored in routine health care settings, especially when implemented at
large scale, was not known, and this implementation-knowledge gap needed to be addressed.
The roles and responsibilities of the different staff officers were unclear, and mechanisms for
recording and reporting in routine settings had not been tested. So, NTWG recommended the
pilot implementation of PITC in one State of India for a period of 3–6 months to finalize the
operational guidance before scale-up to other high HIV settings.[14] Accordingly, a pilot study
was implemented in the entire state of Karnataka (South India, population 64 million, high
HIV prevalence). Karnataka State was chosen for two main reasons: 1) Large state enabling to
test operational feasibility of the strategy when PITC is implemented to scale 2) relatively high
HIV prevalence and better TB-HIV related health infrastructure compared to other states in
India. Duration of three months was chosen for the pilot so as to understand the operational
challenges.
This paper describes the screening procedures deployed (including mechanisms for record-
ing, reporting and monitoring), the experience of implementation, results and challenges of
screening presumptive TB patients for HIV within routine health care settings of Karnataka
State, India.
The specific objectives were to assess
1. the proportion of patients with presumptive TB whose HIV status was ascertained, disag-
gregated district-wise
2. the proportion HIV positive among those who had their HIV status ascertained, disaggre-
gated district-wise
3. the reasons for not ascertaining the HIV status, from the perspective of the health care-
provider
4. the number of HIV cases “newly” diagnosed and the number eligible for antiretroviral ther-
apy (ART eligibility was assessed using WHO-2013 ART guidelines [all TB patients irre-
spective of CD4 count and for presumptive TB patients without TB, a CD4 count<500/
mm3 was considered ART eligible] in line with the recent decision of national AIDS control
organisation in India) [15, 16]
5. The number needed to screen (NNS) to find an additional case of HIV-infection among
“patients with presumptive TB” in comparison to “confirmed TB patients” and those in
reproductive age group (25–54 years).
6. The average increase in daily workload at the HIV testing centers as a result of using this
strategy (obtained by dividing the total number of Presumptive TB patients who underwent
HIV testing by average number of working days in each centre)
Materials and Methods
Ethics approval
Approval of the competent national (Central TB Division and National AIDS Control Organi-
zation) and state authorities (State TB Cell and Karnataka State AIDS prevention and control
society) was obtained for conducting this pilot. Ethics approval was obtained from Institutional
Ethics Committee of the National Tuberculosis Institute, Bangalore, India. Individual written
informed consent from each patient was not taken separately for the study as this was intended
to be a pilot programme implementation and standard operating procedures of National AIDS
Control Programme (NACP) were followed for counselling and HIV testing, which included
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obtaining written consent. The same was approved by the ethics committee including waiver of
a separate informed consent. Given the programmatic nature of the study and availability of
local ethics approval, the Ethics Advisory Group of International Union Against Tuberculosis
and Lung Disease waived the need for ethics review. Data was maintained securely by pro-
gramme staff and electronic databases contained no personal identifiers.
Design
This was a cross-sectional, implementation research study conducted among patients with pre-
sumptive TB examined for diagnostic smear microscopy within the routine health services of
the state of Karnataka, India.
Setting
Karnataka has an estimated 0.21 million people living with HIV in 2011 and accounts for
about 10% of country’s HIV burden.[11] Hence, the state has been classified as ‘high priority’
for HIV interventions by the National AIDS Control Organization (NACO) in India on the
basis of consistently high HIV sero-prevalence rates of>1% among antenatal women and
>5% in other high risk groups. [17, 18] In the state, tuberculosis control programme services
are available through a decentralized network of peripheral health institutions which provide
general health services including diagnosis and treatment for TB.
Patients with presumptive TB (defined as people with cough for two weeks or more with or
without other symptoms suggestive of TB) are identified at the peripheral health centres and
referred for sputum smear microscopy to Designated Microscopy Centres (DMCs), which are
geographically distributed, each covering a population of 0.05 to 0.1 million. In situations
where the patient is unable to physically visit the DMC, the sputum is collected and transported
by the health care workers in the general health system or non-governmental organizations.
The diagnosis of TB is made in accordance with national guidelines, and all diagnosed TB
patients are treated with standardized fully intermittent thrice-weekly short-course regimens
(6–9 months) administered under direct observation. Such patients are registered at one of the
125 sub-district level TB programme management units (which are administrative and super-
visory units for every 10–15 peripheral health institutions) according to Indian programme
guidelines. [19]
As per national policy, HIV status is routinely ascertained for TB patients, and HIV-infected
TB patients are provided Cotrimoxazole Preventive Therapy and referred to Anti-Retroviral
Treatment (ART) centres for initiation on ART. [20] TB patients are referred for free HIV
counselling and testing to one of the 1637 ‘integrated counselling and HIV testing centres’
(ICTC, these are peripheral health institutions with HIV testing services) throughout the state.
At the time of the study, about 90% of DMCs had co-located HIV testing services. Free ART is
provided through a network of 44 ART centres (with at-least one ART centre in every district),
where HIV-infected patients (including TB patients) are started on treatment and care. Once
patients were clinically stable on ART, they were referred to one of 121 Link-ART centres in
the state, closer to the patient’s residence for continuing on ART. These service delivery sites
under NACP follow the national guidelines for counselling, testing, care and treatment of
HIV-infected patients. [21] In line with the higher burden of HIV, there is a higher density of
HIV testing and care centres in the northern parts of the state. [22]
Study population
All patients with presumptive TB examined for diagnostic smear microscopy at the DMCs of
Karnataka state from January-March 2012 formed the study population.
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Sample size and Sampling
Since this was a pilot study intended to be implemented under programmatic conditions to
answer questions of feasibility, it was decided to enrol all patients with presumptive TB (includ-
ing children aged 0–14 years) examined for smear microscopy during the pilot period in all the
31 districts of the state. No patients were excluded. For this reason, sample size calculations
were deemed not relevant for the study.
Planning and implementation
Following the decision of NTWG and based on the official government orders from the
Revised National Tuberculosis Control Programme (RNTCP) and NACP, joint-meetings were
organized between the state level programme managers for planning and rolling out the activi-
ties, training of the staff and ensuring supply chain management of HIV test kits.
All staff involved in data collection, data validation and data entry were trained in carrying
out the respective procedures. The District TB Officers, District nodal officer of HIV/AIDS and
WHO Consultants of the respective study district were trained at state level as master trainers
who then trained the district level staff and oversaw the smooth implementation of study. The
trainings were conducted jointly for the implementing staff (TB field supervisors, Laboratory
technicians of DMCs and HIV testing centres, Counsellors of HIV testing centres) by pro-
gramme managers of the state level with support fromWHO consultants.
Regular supervisory visits were conducted by the state level programme managers (once a
month), WHO Consultants (once a fortnight) and district programme managers (once a fort-
night). Periodic review meetings were conducted to assess the progress of the pilot and address
any implementation issues.
The screening procedures and the patient flow in the health system are shown in Figs 1–3
and described in Table 1.
Since this was a pilot study and the objective was also to study the processes, separate data
collection forms were used to capture individual patient information which included informa-
tion on presence or absence of a co-located ICTC, age, sex, sputum smear result, HIV status,
prior HIV status and CD4 count. These variables were extracted into a pre-tested structured
data collection format by the Senior TB laboratory supervisor (STLS) in co-ordination with the
LT and the counsellor at the HIV testing centre. STLS then coordinated with the district TB/
HIV supervisor and referred to the HIV patient records maintained at the ART centre to obtain
information on the baseline CD4 count. Aggregate data on reasons for non-testing were
extracted from the remarks column of the laboratory register and compiled at district and state
level. Once the pilot period (January-March 2012) was over, the separate data collection for-
mats were discontinued.
Data Validation
The STLSs were trained in extracting data from the laboratory register accurately and expected
to visit the DMCs under their purview once a week to ensure that activities were implemented
as per protocol including recording of HIV status in the laboratory register. This was in turn
monitored by District TB Officer and the WHO field consultant once in a fortnight.
Data entry & Analysis
In this multi-centre study, we used a method of coordinating data capture by utilizing a combi-
nation of three open access sources (EpiData for data entry, Dropbox for sharing data and
TeamViewer for trouble-shooting remotely). [23] All data entry was done by the district-level
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Fig 1. Flow Chart depicting the patient flow and the recording and reportingmechanism, PITC among presumptive TB
patients, Karnataka, India, 2012. PITC-Provider initiated HIV testing and counselling; HIV-Human immunodeficiency virus; TB-
tuberculosis; RNTCP-Revised National Tuberculosis Control Programme; PHI-Peripheral Health Institutions; TU-Tuberculosis
Unit; LT-Laboratory Technician; DMC-Designated Microscopy Centre; PMR-ProgrammeManagement Report.
doi:10.1371/journal.pone.0156487.g001
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Fig 2. Modified format of laboratory form for sputum examination, PITC among presumptive TB patients,
Karnataka, India, 2012.
doi:10.1371/journal.pone.0156487.g002
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data entry operators working for RNTCP. The technique has been detailed elsewhere.[23] Dou-
ble data entry, validation and analysis were done using EpiData software (version 3.1 for entry
and version 2.2.2.182 for analysis, EpiData Association, Odense, Denmark). Given the large
numbers in the study, it is expected to find statistical significance even when the actual differ-
ences between groups are small. Hence, we have refrained from showing results of any statisti-
cal tests and make all the interpretations from programmatic point of view.
Results
Data was obtained from all the 31 districts in the state. This included 645 microscopy centres,
among which 573(89%) had HIV testing services available in the same facility. A total of
115,308 patients with presumptive TB [40% female, mean age of 44 years] were examined for
sputum smear microscopy. HIV status was ascertained for 62,847 (55%) among whom 7,559
(12%) were found to be HIV positive.
The proportion whose HIV status was ascertained along with HIV positive results, disaggre-
gated by age, sex and smear-positivity, is shown in Table 2. HIV testing varied little [ranged
between 50% and 57%] across age groups and sexes. HIV testing rates were two times higher
among patients visiting microscopy centres with co-located HIV testing facilities as compared
to those without. Patients with confirmed smear-positive TB were more likely to be tested for
HIV as compared to those with other types of TB. HIV testing rates varied between 15% and
95% across districts with districts in the northern part of the state performing better as com-
pared to southern part (Table 3, Fig 4).
HIV positivity tended to be lower among elderly age groups, marginally higher among
females as compared to males and varied between 3% and 28% across districts—with a higher
positivity in districts located in the northern part of the state. HIV positivity was similar
among smear-positive and smear-negative patients (Table 3, Fig 5).
Fig 3. Modified format of laboratory register, PITC among presumptive TB patients, Karnataka, India, 2012.
doi:10.1371/journal.pone.0156487.g003
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Table 1. Operational procedures in provider-initiated HIV counselling and testing among patients
with presumptive TB in Karnataka state, India, January-March 2012.
Operational Procedure Steps
Procedure at Designated Microscopy
Centre (DMC)
Step 1: All Presumptive TB patients (including those coming
for a repeat sputum examination) attending the
designated microscopy centre (DMC) for diagnosis of TB
were offered HIV counselling and testing by the DMC
laboratory technician (DMC LT).
Step 2: DMC LT after receiving the ﬁrst sputum sample,
referred the patient to the nearest, preferably the co-
located HIV testing facility. If the patient was known to be
HIV positive (in case of referral from ART centres, ICTCs
or blood banks), the information regarding the HIV status
was recorded in the laboratory register and the patient
was not referred any further. The date of HIV testing was
extracted from the ART patient booklet; if not available,
the approximate date of HIV testing was documented as
per patient’s history. The information regarding ‘HIV
status’ and ‘date of HIV testing’ was documented in the
RNTCP laboratory register (in a new column added for
the purpose). In the case of presumptive TB patients
whose HIV status was not known or HIV negative, LT
referred them to the nearest or co-located HIV testing
facility.
Step 3: In cases where only the sputum samples reached
the DMC (in the absence of the patient), it was recorded
in the remarks column of the laboratory register. No active
effort to track and offer an HIV test to such patients was
undertaken. However, if there was a HIV testing facility at
the peripheral health facilities (as in some districts like
Bagalkot and Belgaum), HIV testing was offered to all
presumptive TB patients whose sputum was collected at
the collection points. The information regarding HIV status
and date of HIV testing was then collected by DMC LT
from the collection centres and this was updated in the
laboratory register.
Step 4: The counsellor at the HIV testing centre provided the
feedback regarding HIV status (Positive/Negative/
Indeterminate/Opted out) and date of HIV testing in the
RNTCP laboratory form for sputum examination. A new
ﬁeld to capture HIV status and date of HIV testing was
created in the RNTCP laboratory form for sputum
examination. DMC LT updated the laboratory register
based on the feedback on the laboratory form.
Alternatively, the DMC LT discussed with the counsellor at
the end of the day and updated the HIV status in the
laboratory register—this is as per the national guidelines
of shared conﬁdentiality among health care providers for
providing optimum care for the patient.
Step 5: The predominant reason for not ascertaining the HIV
status, wherever known, was recorded in the remarks
column.
Procedure at the Integrated Counselling
and HIV Testing Centre (ICTC)
Step 1: Presumptive TB patients coming to the ICTCs were
offered counselling and testing as per the norms and
standard operating procedures of the NACP.
Step 2: All referrals were recorded in the ICTC counselling
register as referrals from RNTCP.
Step 3: Presumptive TB patients who were known to be HIV
positive and patients who had tested HIV negative within
last 6 months were not re-tested. Patients who had an
indeterminate result were re-offered the HIV test.
(Continued)
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Of all presumptive TB patients in the study, 4525 were already diagnosed as HIV positive
prior to the study. Of the remaining 110783 patients with unknown status prior to the study,
HIV status could be ascertained for 53627 (48%) patients, in whom an additional 3034 HIV pos-
itive patients were identified. Thus, of a total of 7,559 HIV-positive patients identified, 3,034
(40%) were newly diagnosed with HIV infection as a result of this screening effort. Among
3,034 newly diagnosed HIV cases, ART eligibility could be assessed for 2,244 (74%) of whom
1,992 (89%) had CD4 count500 and were found to be eligible for ART initiation. (Table 4)
When hypothetically comparing potential policies for HIV testing, the option of limiting
HIV testing to adults in 25–54 years was most efficient. In this analysis, we excluded patients
with previously known HIV status and examined the yield of HIV among those with a previ-
ously unknown HIV status. (Table 5)
The reasons for non-ascertainment of HIV status, collected from 37,300 (72%) of the 52,461
patients without HIV testing, is shown in Table 6. The key reason for non-testing was related
to the fact that sputum samples were collected at peripheral health institutions and transported
to microscopy centres instead of referring patients.
A workload assessment indicated that the median [inter quartile range] increase in the
number of clients to be tested for HIV per day as a result of this intervention was 2 [1–2].
About 90% of the HIV testing centres had an increase of less than or equal to five clients per
day (Table 7).
Discussion
The study showed that the strategy of HIV testing among patients with presumptive TB could
be feasibly and effectively implemented within the routine health system. We consider the
Table 1. (Continued)
Operational Procedure Steps
Step 4: For patients with HIV positive results, the counsellor
linked these patients to the nearest ART centre available
in the district/state. This was done by giving a referral
form and explaining to the patient about how to access
the centre. The patient was given the contact details of
the district programme managers for any assistance.
Step 5: The counsellor then documented the HIV status in
the RNTCP laboratory form as feedback to DMC LT. The
counsellor also assisted the DMC LT to update the
laboratory register with information on HIV status.
Recording RNTCP laboratory form for sputum examination (Fig 2):
A new ﬁeld was created to capture the HIV status and
date of HIV testing which was completed by the
counsellor/LT at the HIV testing centre wherein one of the
following options was noted—Positive, Negative,
Indeterminate, Opted out.
RNTCP laboratory register (Fig 3): A column to capture
HIV status was added in the laboratory register (Positive,
Negative, Unknown)
Reporting The following indicators were added in the monthly report
submitted by each DMC to RNTCP: (1) Of Presumptive
TB patients examined for diagnosis, number with known
HIV status. (2) Of above, number HIV positive. This
information was then compiled quarterly in the district and
State level programme management reports and reported
in routine RNTCP surveillance.
doi:10.1371/journal.pone.0156487.t001
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intervention was feasible for the following reasons: 1) All the interventions including recording
and reporting were implemented in a large state by the existing staff and resources. One of the
major strengths of this study is that it was done with complete engagement of the national pro-
grammes from the stage of planning to execution, monitoring, recording and reporting. The
existing programme resources were used for implementing all the activities without the need
for any extra budget. There was a total increase in the need for HIV test kits which in turn
needed optimisation of supply chain management and we need to factor-in this aspect in future
procurement cycles. 2) There was minimal additional workload in the HIV testing centres. Bar-
ring a small proportion of tertiary care institutes with high patient load, the average daily
increase in number of patients requiring to be tested was low at more than 95% of HIV testing
centres. In centres which had an increase of more than 10 clients tested per day, additional staff
may need to be deployed. 3) Only 4% of the patients opted out of HIV testing indicating high
acceptability of this intervention among the patient population.
We consider the strategy to be effective as it led to finding thousands of new HIV-positive
patients who were ART eligible. Nearly 40% of the 7559 HIV-positive cases were ‘newly diag-
nosed’ as a result of this strategy with almost 90% of them eligible for ART as per the existing
criteria for starting ART. Nearly half of all presumptive TB patients were tested for HIV,
although district-wise analysis indicated large variability. This is probably due to variation in
availability of HIV testing facilities and their co-location at the sputum microscopy centres.
There are several important points that merit discussion. First, while WHO now recom-
mends routine HIV testing of all presumptive TB patients, the operational guidance as to how
to do this is lacking. This is among the first studies to fill that gap and addresses an area of
Table 2. Ascertainment of HIV status and HIV positivity among patients with presumptive TB in Karnataka state, India, January-March 2012.
Parameter Number examined for sputum smear microscopy Number (%) with HIV status ascertained Number (%) HIV Positive
Total 115308 62847 (55) 7559 (12)
Age (years)
00–14 3808 1887 (50) 252 (13)
15–24 12804 7326 (57) 514 (7)
25–34 19595 11276 (57) 2157 (19)
35–44 20707 11738 (57) 2580 (22)
45–54 20336 11080 (55) 1333 (12)
55–64 18808 10022 (53) 510 (5)
65 18857 9448 (50) 205 (2)
Unknown 393 70 (18) 8 (11)
Sex
Male 69189 37498 (54) 4088 (11)
Female 46068 25335 (55) 3465 (14)
Transgender 7 6 (86) 5 (83)
Unknown 44 8 (18) 1 (13)
Sputum Smear status
Smear Positive 9789 7071 (72) 802 (11)
Smear Negative 105519 55776 (53) 6757 (12)
HIV testing facility
Not co-located 6248 1784 (29) 114 (6)
Co-located 109060 61063 (56) 7445 (12)
TB—Tuberculosis; HIV—Human immunodeﬁciency virus;
doi:10.1371/journal.pone.0156487.t002
HIV Testing among Presumptive TB Patients in India
PLOS ONE | DOI:10.1371/journal.pone.0156487 May 31, 2016 11 / 19
global priority. This was also a national priority and addressed a specific request from the
NTWG of Government of India.[14] Previous studies on this issue have focussed on assessing
prevalence of HIV among presumptive TB patients rather than testing implementation models
in routine programme settings. [4–10] These findings were presented back to NTWG and
a decision to nationally scale up this intervention across all high HIV settings was made.
Changes in recording and reporting have already been adopted by the national TB and HIV
programmes in India. While we cannot attribute it directly, we note that some of these changes
are now reflected in global guidance. [24]
Second, this is one of the largest studies on the issue of HIV testing among presumptive TB
patients with more than 0.1 million patients screened in a period of three months across one of
the HIV priority states of India. Being carried out in the routine health care setting, this study
gives valuable information of the ground realities and challenges in implementing a new strat-
egy within the general health system.
Table 3. Ascertainment of HIV status and HIV positivity among patients with presumptive TB, district-wise, in Karnataka state, India, January-
March 2012.
Parameter Number examined for sputum smear microscopy Number (%) with HIV status ascertained Number (%) HIV Positive
Bagalkot 3351 3021 (90) 812 (27)
Bangalore City 9524 2330 (25) 251 (11)
Bangalore Rural 2054 591 (29) 39 (7)
Bangalore Urban 5311 816 (15) 61 (8)
Belgaum 8569 8122 (95) 959 (12)
Bellary 3533 2827 (80) 380 (13)
Bidar 2987 2540 (85) 137 (5)
Bijapur 2801 1873 (67) 530 (28)
Chamarajanagar 2735 899 (33) 117 (13)
Chikkaballapur 2523 1307 (52) 91 (7)
Chikmagalur 2928 1169 (40) 84 (7)
Chitradurga 2365 1613 (68) 71 (4)
Dakshina Kannada 4116 2761 (67) 170 (6)
Davanagere 3156 1070 (34) 250 (23)
Dharwad 3899 3261 (84) 451 (14)
Gadag 2237 1321 (59) 216 (16)
Gulbarga 4348 1835 (42) 193 (11)
Hassan 4938 2374 (48) 156 (7)
Haveri 2223 877 (40) 113 (13)
Kodagu 1317 661 (50) 33 (5)
Kolar 2733 1841 (67) 283 (15)
Koppal 2435 2032 (83) 446 (22)
Mandya 5026 2327 (46) 187 (8)
Mysore 6962 2407 (35) 180 (8)
Raichur 3201 2595 (81) 444 (17)
Ramanagara 3052 1463 (48) 38 (3)
Shimoga 3576 1788 (50) 209 (12)
Tumkur 5955 3391 (57) 405 (12)
Udupi 2455 1187 (48) 84 (7)
Uttara Kannada 3783 1573 (42) 97 (6)
Yadgiri 1215 975 (80) 72 (7)
doi:10.1371/journal.pone.0156487.t003
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Fig 4. Ascertainment of HIV status among patients with presumptive TB, district-wise, in Karnataka
state, India, January-March 2012.
doi:10.1371/journal.pone.0156487.g004
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Fig 5. HIV positivity among patients with presumptive TB, district-wise, in Karnataka state, India,
January-March 2012.
doi:10.1371/journal.pone.0156487.g005
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Table 4. Antiretroviral therapy (ART) eligibility in newly diagnosed HIV among patients with presumptive TB, Karnataka state, India, January-
March 2012.
Characteristic TB patients Presumptive TB patients without TB Total
Number of newly diagnosed HIV cases 395 2639 3034
Number (%) assessed for ART eligibility 395 (100) 1849 (70) 2244 (74)
Number (%) ART eligible 395 (100) 1597 (87) 1992 (89)
Median (IQR) CD4 count 149 (74–290) 195 (89–361) 189 (87–355)
doi:10.1371/journal.pone.0156487.t004
Table 5. Number needed to screen (NNS) to find one new (previously undiagnosed) case of HIV, by hypothetical strategy, Karnataka state, India,
January-March 2012.





HIV testing for all smear-positive TB patients 6035 395 (6.5) 15
HIV testing for all presumptive TB patients 53627 3034 (5.7) 18
HIV testing of all presumptive TB patients in the age group
25–54 years
27769 2408 (8.7) 11
doi:10.1371/journal.pone.0156487.t005
Table 6. Reasons for non-ascertainment of HIV status among presumptive TB patients, Karnataka
state, India, January-March 2012.
Reasons for non-ascertainment of HIV status Number Percentage
Sputum specimens reaching microscopy centre instead of presumptive TB
patients
20,454 54%
Non-availability of HIV test kits 7,179 19%
Non-availability of staff (Laboratory Technician, Counsellor) at the time of referral
(due to leave, outreach duty, travel to attend meetings)
3,681 10%
HIV testing facility not co-located at microscopy centres 2,332 6%
Opted out of HIV testing 1,659 4%
Other reasons (lack of awareness among staff, gaps in recording, refusal to test
due to workload, non-referral due to misconceptions of the staffs, death)
2,395 7%
Total 37,700* 100%
* Data about reasons for non-testing was available from 37,300 (72%) of the 52,461 patients
doi:10.1371/journal.pone.0156487.t006
Table 7. Increase in workload at HIV testing centres due to strategy of ‘routine HIV testing of presump-
tive TB patients’, Karnataka state, India, January-March 2012.
Average increase in number
of clients tested for HIV
Number (%) [based on actual
numbers tested for HIV]
Number (%) [assuming all TB
suspects will be tested for HIV]
1–2 clients per day 396 (69.5) 252 (44.2)
3–5 clients per day 141 (24.7) 224 (39.3)
6–10 clients per day 31 (5.4) 79 (13.9)
>10 clients per day 2 (0.4) 15 (2.6)
HIV-Human immunodeﬁciency virus;
doi:10.1371/journal.pone.0156487.t007
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Third, we found that nearly 90% of HIV-infected presumptive TB patients (without TB)
were eligible for ART. This is similar to the findings of two recent studies from Zimbabwe and
India.[25, 26] As a public health approach, this is another subset of patients (similar to HIV-
infected persons having active TB disease, hepatitis B virus infection with severe chronic liver
disease, being pregnant or breast feeding, being aged under five years, and living in a sero-dis-
cordant relationship) in whom ART should be recommended irrespective of CD4 count. This
strengthens the argument about moving towards a HIV ‘test and treat’ strategy for presumptive
TB patients. This is in line with the recent guidance fromWHO which calls for starting all HIV
patients on ART irrespective of CD4 count.[27]
Fourth, about half of the presumptive TB patients were not tested for HIV. Not surprisingly,
HIV testing was more likely in DMCs with co-located HIV testing facilities. This justifies the
ongoing efforts of the national programmes to prioritise setting up of new HIV testing facilities
at hospitals having sputum microscopy facilities. This, however, will not address the major rea-
son for non-testing in a substantial proportion of presumptive TB patients in whom sputum
samples were collected and transported from peripheral health institutions to DMCs—such
patients will miss the opportunity to get HIV tested at DMC. This calls for further decentraliza-
tion of the HIV testing services to all the peripheral health institutions and sputum collection
centres and national programmes should seriously consider this strategy to improve the uptake
of HIV testing. We suggest scaling-up the use of rapid HIV screening tests at all the PHIs and
those who are screened positive may be referred for further testing and confirmation at the
ICTCs. The other programmatic challenge is to improve the procurement and supply chain
management of HIV test kits to enhance HIV test uptake. Unavailability of laboratory techni-
cian or counsellors at DMC and/or ICTC was another reason for lack of HIV testing. This can
be addressed by training the other staff within the general health system and motivating them
to perform HIV testing in line with the overall approach to integrate NACP into the general
health system and this would be sustainable in the long term.
Fifth, we captured data in an innovative manner using the freely available resources for data
entry, storage, sharing and trouble shooting. This approach to ensuring quality of data capture
in multicentre operational research in resource-constrained settings has been a great lesson.
[23]
There were some limitations to our study given the operational nature of the study and reli-
ance on routinely collected data. In this pilot, we could not capture the data among smear nega-
tive presumptive TB patients as to how many were eventually diagnosed with smear negative
pulmonary TB and extrapulmonary TB. In assessing ART eligibility, information on whether
the person was living in a sero-discordant relationship would have been useful, but was not
captured. Including these criteria would have increased the number of people eligible for ART
and hence the numbers obtained in this study are an underestimate. Furthermore, CD4 cell
count data were missing in 30% of the HIV positive patients. Information on how many newly
diagnosed HIV infected presumptive TB patients were put on ART and Co-trimoxazole Pro-
phylactic Therapy later was also not documented. Information such as this would be very use-
ful to assess if this strategy indeed increased the overall number of HIV-infected persons
placed on ART and if it reduced the delay in initiating ART. Further studies are required to
assess this and the impact on reducing overall HIV-TB associated mortality. While there could
be multiple reasons in an individual for non-testing of HIV, only one predominant reason was
captured and that too from the provider’s perspective. In about one-third of patients, reason
for non-testing was not mentioned and this is a serious limitation. Further, we do not have
any information if this sub-group is similar to the rest in whom we know the reason for non-
testing. Future research involving qualitative methods should be undertaken to understand
patients’ perspectives for not getting tested for HIV.
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WHO and Joint United Nations Programme on HIV/AIDS (UNAIDS) have both embraced
a bold new vision of “90-90-90” strategy which emphasizes the need to detect 90% of all HIV
infected patients in the community, treat 90% of those detected with antiretroviral therapy
(ART) and achieve viral suppression in 90% of those treated, and this has been reinforced by a
similar 90-90-90 vision for TB control from the global STOP TB partnership.[28, 29] Achiev-
ing these ambitious targets will require innovative efforts to find previously undetected HIV
cases in the community. Testing presumptive TB patients in Karnataka proved to be an effi-
cient means of HIV case-finding, and may complement that effort.
In conclusion, this operational research demonstrated a feasible way to make HIV testing
among presumptive TB patients a reality in routine health settings. Several operational chal-
lenges were noted which provide useful lessons for moving forward.
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